The diagnosis and investigation of adrenal insufficiency in adults

Annals of Clinical Biochemistry

Volumn 46, Issue 5, 2009, Pages 351-367

  Wallace, Ian ^a   Cunningham, Sean ^b   Lindsay, John ^a  

^a ALTNAGELVIN HOSPITAL   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCAGON; HYDROCORTISONE; METYRAPONE;

ADRENAL BIOPSY; ADRENAL HEMORRHAGE; ADRENAL INSUFFICIENCY; ALDOSTERONE BLOOD LEVEL; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CORTICOSTEROID METABOLISM; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFECTION; INSULIN TOLERANCE TEST; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REVIEW;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; FEMALE; HORMONES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MODELS, BIOLOGICAL; PITUITARY-ADRENAL SYSTEM;

EID: 69749119782     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009101     Document Type: Review

References (131)

1. Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 2005;34:293-313, viii (Pubitemid 40602722)
2. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-520 (Pubitemid 26044473)
3. Lin L, Achermann JC. The adrenal. Horm Res 2004;62(Suppl 3):22-29
4. Stocco DM, Clark BJ. Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 1996;51: 197-205 (Pubitemid 26054426)
5. Salvatori R. Adrenal insufficiency. JAMA 2005;294:2481-2488
6. Taylor AL, Fishman LM. Corticotropin-releasing hormone. N Engl J Med 1988;319:213-222
7. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984;5:1-24
8. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrin Metabol Clin N Am 2005;34:271-292
9. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971;33:14-22
10. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 1987;43:113-173
11. Buijs RM, Hermes MH, Kalsbeek A. The suprachiasmatic nucleus- paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog Brain Res 1998;119:365-382 (Pubitemid 29099983)
12. Clayton PJ. Depression subtyping: treatment implications. J Clin Psychiatry 1998;59(Suppl 16):5-12; discussion 40-42
13. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996;81:2468-2473 (Pubitemid 26240262)
14. Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005;26:775-799
15. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001;15:61-78
16. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 1988;2:986-989 (Pubitemid 18254266)
17. May ME, Vaughan ED, Carey RM. Adrenocortical Insufficiency - Clinical Aspects. New York: Thieme Medical, 1989
18. Yatagai T, Kusaka I, Nakamura T, et al. Close association of severe hyponatremia with exaggerated release of arginine vasopressin in elderly subjects with secondary adrenal insufficiency. Eur J Endocrinol 2003;148:221-226 (Pubitemid 36305688)
19. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 1989;321:492-496 (Pubitemid 19203872)
20. Willis AC, Vince FP. The prevalence of Addison's disease in Coventry, UK. Postgrad Med J 1997;73:286-288
21. Lovas K, Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol (Oxf) 2002;56:787-791 (Pubitemid 34785911)
22. Addison T. On the Constitutional and Local Effects of Diseases of the Supra-Renal Capsules. London: Warren & Son, 1855
23. Soule S. Addison's disease in Africa - a teaching hospital experience. Clin Endocrinol (Oxf) 1999;50:115-120 (Pubitemid 29079376)
24. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-364 (Pubitemid 34651950)
25. Friderichsen C. Waterhouse-Friderichsen syndrome. Acta Endocrinol 1955;18:482-492
26. Hamilton D, Harris MD, Foweraker J, Gresham GA. Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection. J Clin Pathol 2004;57:208-209 (Pubitemid 38177767)
27. Liatsikos EN, Kalogeropoulou CP, Papathanassiou Z, et al. Primary adrenal tuberculosis: role of computed tomography and CT-guided biopsy in diagnosis. Urol Int 2006;76:285-287
28. Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf) 2001;54:633-639
29. Smolyar D, Tirado-Bernardini R, Landman R, Lesser M, Young I, Poretsky L. Comparison of 1-micro g and 250-micro g corticotropin stimulation tests for the evaluation of adrenal function in patients with acquired immunodeficiency syndrome. Metabolism 2003;52:647-651 (Pubitemid 36896295)
30. Seidenwurm DJ, Elmer EB, Kaplan LM, Williams EK, Morris DG, Hoffman AR. Metastases to the adrenal glands and the development of Addison's disease. Cancer 1984;54:552-557 (Pubitemid 14087887)
31. Barker N. The pathologic anatomy in twenty-eight cases of Addison's disease. Arch Pathol 1929;8:432-450
32. Limal JM, Bouhours-Nouet N, Rouleau S, Gatelais F, Coutant R. Acute adrenal insufficiency in the newborn. Arch Pediatr 2006;13:1358-1363
33. Hughes IA. Congenital adrenal hyperplasia: a lifelong disorder. Horm Res 2007;68:S84-9
34. Mosser J, Lutz Y, Stoeckel ME, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3:265-271 (Pubitemid 24060941)
35. Laureti S, Aubourg P, Calcinaro F, et al. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab 1998;83:3163-3168 (Pubitemid 28500951)
36. Shapiro E, Krivit W, Lockman L, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000;356:713-718 (Pubitemid 30663240)
37. Clark AJL, Weber A. Adrenocorticotropin insensitivity syndromes. Endoc Rev 1998;19:828-843
38. de Jong FH, Mallios C, Jansen C, Scheck PA, Lamberts SW. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab 1984;59:1143-1147 (Pubitemid 15223350)
39. McKone EF, Tonelli MR, Aitken ML. Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis. Pediatr Pulmonol 2002;34:381-383
40. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 2001;55:735-740 (Pubitemid 34008744)
41. Oelkers W. Adrenal insufficiency. N Engl J Med 1996;335:1206-1212
42. Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA 1999;282:671-676
43. Revermann T, Soergel M, Hellinger A, Klaus G. Stimulated cortisol secretion is not correlated with prednisone dose or with steroid side-effects in children after renal transplantation. Pediatr Transplant 2002;6:288-294 (Pubitemid 35000968)
44. Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab 1965;25:11-16
45. LaRochelle GE Jr, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med 1993;95:258-264
46. Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500 (Pubitemid 30056739)
47. Roche Cobas E170/Elecsys Cortisol reagent, catalog number 11875116, data sheet 2008-2102, V 13 English
48. Siemens Immulite 2500 Cortisol reagent, catalog number L5KCO2, data sheet PIL5KCO-3, 2005-2104-05
49. Beckman Coulter Access DXi Cortisol reagent, catalog number 33600, data sheet 170157G, 2006
50. Steele BW, Wang E, Palmer-Toy DE, Killeen AA, Elin RJ, Klee GG. Total long-term within-laboratory precision of cortisol, ferritin, thyroxine, free thyroxine and thyroid-stimulating hormone assays based on a College of American Pathologists fresh frozen serum study. Arch Pathol Lab Med 2005;129:318-322
51. Middle J, UK NEQAS for Steroid Hormones, Birmingham Quality, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK (with permission)
52. Cohen J, Ward G, Prins J, Jones M, Venkatesh B. Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med 2006;32:1901-1905 (Pubitemid 44607383)
53. Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 2007;92:1326-1333 (Pubitemid 46556405)
54. Barnes SC, Swaminathan R. Effect of albumin concentration on serum cortisol measured by the Bayer Advia Centaur assay. Ann Clin Biochem 2007;44:79-82 (Pubitemid 46168806)
55. Qureshi AC, Bahri A, Breen LA, et al. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol (Oxford) 2007;66:632-635 (Pubitemid 46699528)
56. Brennan A, O'Connor KA, Plant WD, O'Halloran DJ. Nephrotic syndrome: cause of an abnormal response to the rapid ACTH stimulation test. Nephrol Dial Transplant 2004;19:477-478 (Pubitemid 38196003)
57. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-1893
58. Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994;79:923-931 (Pubitemid 24342224)
59. Barth JH, Seth J, Howlett TA, Freedman DB. A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 1995;32(Pt 5):442-449
60. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med 2003;139:194-204
61. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998;83:1558-1562 (Pubitemid 28501021)
62. Gonzalbez J, Villabona C, Ramon J, et al. Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol (Oxford) 2000;53:199-204
63. Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol (Oxf) 2005;63:499-505 (Pubitemid 41626743)
64. Graybeal ML, Fang VS. Physiological dosing of exogenous ACTH. Acta Endocrinol (Copenhagen) 1985;108:401-406
65. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991;72:773-778 (Pubitemid 21921764)
66. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995;80:1301-1305
67. Thaler LM, Blevins LS Jr. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 1998;83:2726-2729
68. Alia P, Villabona C, Gimenez O, Sospedra E, Soler J, Navarro MA. Profile, mean residence time of ACTH and cortisol responses after low and standard ACTH tests in healthy volunteers. Clin Endocrinol (Oxf) 2006;65:346-351 (Pubitemid 44244924)
69. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) 1998;49:287-292 (Pubitemid 28448936)
70. Reynolds RM, Stewart PM, Seckl JR, Padfield PL. Assessing the HPA axis in patients with pituitary disease: a UK survey. Clin Endocrinol (Oxf) 2006;64:82-85
71. Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996;44:141-146 (Pubitemid 26042966)
72. Coco G, Dal Pra C, Presotto F, et al. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006;91:1637-1645
73. Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamopituitary-adrenal axis. Clin Endocrinol (Oxf) 2008;69:603-607
74. Plumpton FS, Besser GM. The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. Br J Surg 1968;55:857
75. Courtney CH, McAllister AS, McCance DR, et al. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol (Oxf) 2000;53:431-436
76. Tsatsoulis A, Shalet SM, Harrison J, Ratcliffe WA, Beardwell CG, Robinson EL. Adrenocorticotrophin (ACTH) deficiency undetected by standard dynamic tests of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1988;28:225-232 (Pubitemid 18055760)
77. Lindholm J. The insulin hypoglycaemia test for the assessment of the hypothalamic-pituitary-adrenal function. Clin Endocrinol (Oxf) 2001;54:283-286 (Pubitemid 32234189)
78. Suliman AM, Smith TP, Labib M, Fiad TM, McKenna TJ. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency. Clin Endocrinol (Oxf) 2002;56:533-539 (Pubitemid 34429629)
79. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary- adrenal axis. Clin Endocrinol (Oxf) 1994;40:603-609
80. Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 2002;87:5470-5475 (Pubitemid 36034346)
81. Zarkovic M, Ciric J, Stojanovic M, et al. Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. J Clin Endocrinol Metab 1999;84:3170-3173 (Pubitemid 30646939)
82. Gonc EN, Kandemir N, Kinik ST. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood. Horm Res 2003;60:191-197 (Pubitemid 37256066)
83. Soule S, Van Zyl Smit C, Parolis G, et al. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism. Clin Endocrinol (Oxf) 2000;53:221-227 (Pubitemid 30643457)
84. Streeten DH, Anderson GH Jr, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 1996;81:285-290 (Pubitemid 26035035)
85. Giordano R, Picu A, Bonelli L, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol (Oxf) 2008;68:935-941 (Pubitemid 351703953)
86. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol (Oxf) 1987;26:53-59 (Pubitemid 17015965)
87. Dullaart RP, Pasterkamp SH, Beentjes JA, Sluiter WJ. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test. Clin Endocrinol (Oxf) 1999;50:465-471
88. Borst GC, Michenfelder HJ, O'Brian JT. Discordant cortisol response to exogenous ACTH and insulin-induced hypoglycemia in patients with pituitary disease. N Engl J Med 1982;306:1462-1464
89. Cunningham SK, Moore A, McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med 1983;143:2276-2279 (Pubitemid 14209732)
90. Ammari F, Issa BG, Millward E, Scanion MF. A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. Clin Endocrinol (Oxf) 1996;44:473-476 (Pubitemid 26141693)
91. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003;88:3149-3154 (Pubitemid 36877487)
92. Bangar V, Clayton RN. How reliable is the short synacthen test for the investigation of the hypothalamic-pituitary-adrenal axis? Eur J Endocrinol 1998;139:580-583
93. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84:838-843 (Pubitemid 29138205)
94. Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2006;91:43-47 (Pubitemid 43069115)
95. Gleeson HK, Walker BR, Seckl JR, Padfield PL. Ten years on: safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab 2003;88:2106-2111
96. Mukherjee JJ, de Castro JJ, Kaltsas G, et al. A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol (Oxf) 1997;47:51-60 (Pubitemid 27313988)
97. Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002;87:2745-2750
98. Spathis GS, Bloom SR, Jeffcoate WJ, et al. Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH. Clin Endocrinol (Oxf) 1974;3:175-186
99. Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol (Oxf) 1989;31:527-533 (Pubitemid 19260633)
100. Gibson SC, Hartman DA, Schenck JM. The endocrine response to critical illness: update and implications for emergency medicine. Emerg Med Clin North Am 2005;23:909-29, xi
101. Cooper MS, Stewart PM. Adrenal insufficiency in critical illness. J Intensive Care Med 2007;22:348-362
102. Schuetz P, Muller B. The hypothalamic-pituitary-adrenal axis in critical illness. Endocrinol Metab Clin North Am 2006;35:823-38, x
103. Vanhorebeek I, Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 2006;22:1-15, v (Pubitemid 43037106)
104. Reincke M, Allolio B, Wurth G, Winkelmann W. The hypothalamic-pituitary- adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:151-156 (Pubitemid 23206794)
105. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995;80:1799-1803
106. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-1796 (Pubitemid 35366095)
107. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006;91:3725-3745
108. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871 (Pubitemid 34898534)
109. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124
110. LaRosa SP. Use of corticosteroids in the sepsis syndrome: what do we know now? Cleve Clin J Med 2005;72:1121-1127
111. Dimopoulou I, Tsagarakis S, Douka E, et al. The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: incidence of hypo-responsiveness and relationship to outcome. Intensive Care Med 2004;30:1216-1219 (Pubitemid 38833379)
112. Annane D, Bellissant E. Prognostic value of cortisol response in septic shock. JAMA 2000;284:308-309
113. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
114. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004;350:1629-1638 (Pubitemid 38501164)
115. Ho JT, Al-Musalhi H, Chapman MJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006;91:105-114 (Pubitemid 43069125)
116. Davidson JSBM, Croxson MS, Chiu W, Lewis JG. A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests. Ann Clin Biochem 2006;43:237-239 (Pubitemid 43668161)
117. le Roux CW, Sivakumaran S, Alaghband-Zadeh J, Dhillo W, Kong WM, Wheeler MJ. Free cortisol index as a surrogate marker for serum free cortisol. Ann Clin Biochem 2002;39:406-408 (Pubitemid 34743644)
118. Blevins LS Jr, Shankroff J, Moser HW, Ladenson PW. Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy. J Clin Endocrinol Metab 1994;78:261-265 (Pubitemid 24061736)
119. Lindsay JR, Shanmugam VK, Oldfield EH, Remaley AT, Nieman LK. A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome. J Endocrinol Invest 2006;29:983-988
120. Verschraegen I, Anckaert E, Schiettecatte J, et al. Multicenter evaluation of a rapid electrochemiluminescent adrenocorticotropic hormone (ACTH) immunoassay. Clin Chim Acta 2007;380:75-80 (Pubitemid 46498031)
121. Talbot JA, Kane JW, White A. Analytical and clinical aspects of adrenocorticotrophin determination. Ann Clin Biochem 2003;40:453-471 (Pubitemid 37152198)
122. Siemens Immulite 2500 ACTH reagent, catalog number L5KAC2, data sheet PIL5KAC-2, 2006-2012-29
123. Roche Cobas ACTH E170/Elecsys reagent, catalog number, 03255751, data sheet 2007-2107, V 4 English
124. UK NEQAS for Peptide Hormones, Department of Clinical Biochemistry, Royal Infirmary, Edinburgh, UK, with permission. Further details may be obtained from the organisers, Dr A Ellis and Dr C Sturgeon
125. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1993;77:1308-1312 (Pubitemid 23345487)
126. Maghnie M, Uga E, Temporini F, et al. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol 2005;152:735-741 (Pubitemid 40744542)
127. Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 2003;88:4193-4198 (Pubitemid 37153719)
128. Marzotti S, Falorni A. Addison's disease. Autoimmunity 2004;37:333-336
129. Falorni A, Laureti S, Nikoshkov A, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clin Exp Immunol 1997;107:341-346 (Pubitemid 27049262)
130. Sawczuk IS, Reitelman C, Libby C, Grant D, Vita J, White RD. CT findings in Addison's disease caused by tuberculosis. Urol Radiol 1986;8:44-45 (Pubitemid 16119281)
131. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-429 (Pubitemid 36262654)